Form 8-K - Current report:
SEC Accession No. 0001274737-22-000080
Filing Date
2022-12-05
Accepted
2022-12-05 16:22:20
Documents
13
Period of Report
2022-12-05
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K exdx-20221205.htm   iXBRL 8-K 43317
2 EX-10.1 debzackconsultingagreement.htm EX-10.1 53836
  Complete submission text file 0001274737-22-000080.txt   249750

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT exdx-20221205.xsd EX-101.SCH 1896
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT exdx-20221205_lab.xml EX-101.LAB 24831
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT exdx-20221205_pre.xml EX-101.PRE 13039
7 EXTRACTED XBRL INSTANCE DOCUMENT exdx-20221205_htm.xml XML 11232
Mailing Address 1261 LIBERTY WAY VISTA CA 92081
Business Address 1261 LIBERTY WAY VISTA CA 92081 (760) 560-1501
EXAGEN INC. (Filer) CIK: 0001274737 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39049 | Film No.: 221445225
SIC: 8071 Services-Medical Laboratories